Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Fernando Vega-Díaz"'
Publikováno v:
Acta Pharmaceutica, Vol 67, Iss 2, Pp 215-226 (2017)
Acta Pharmaceutica
Volume 67
Issue 2
Acta Pharmaceutica
Volume 67
Issue 2
γ-Ethyl-γ-phenyl-butyrolactone (EFBL) is a structural combination of the anticonvulsant γ-hydroxy-γ-ethyl-γ-phenylbutyramide (HEPB) and the hypnotic γ-butyrolactone (GBL), which inherits both properties. To clarify its mechanism of action, the
Publikováno v:
Acta Pharmaceutica, Vol 65, Iss 4, Pp 443-452 (2015)
Glutamate (Glu) is a major excitatory neurotransmitter involved in epilepsy. Glu is synthesized by glutamate dehydrogenase (GDH, E.C. 1.4.1.3) and dysfunction of the enzymatic activity of GDH is associated with brain pathologies. The main goal of thi
Publikováno v:
ISRN Pharmacology
Glutamate dehydrogenase (GDH, E.C. 1.4.1.3.) is a key enzyme for the biosynthesis and modulation of glutamate (GLU) metabolism and an indirectγ-aminobutyric acid (GABA) source, here we studied the effect of anticonvulsants such as pyridoxal phosphat
Publikováno v:
Acta Pharmaceutica
Volume 65
Issue 4
Volume 65
Issue 4
Glutamate (Glu) is a major excitatory neurotransmitter involved in epilepsy. Glu is synthesized by glutamate dehydrogenase (GDH, E.C. 1.4.1.3) and dysfunction of the enzymatic activity of GDH is associated with brain pathologies. The main goal of thi